Aviva’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $77.1M | Buy |
199,336
+1,719
| +0.9% | +$638K | 0.11% | 154 |
|
|
2026
Q1 | $57.9M | Buy |
197,617
+5,634
| +3% | +$1.85M | 0.1% | 207 |
|
|
2025
Q4 | $67.3M | Buy |
191,983
+11,284
| +6% | +$3.81M | 0.11% | 167 |
|
|
2025
Q3 | $58.4M | Sell |
180,699
-222,629
| -55% | -$69.2M | 0.11% | 188 |
|
|
2025
Q2 | $157M | Sell |
403,328
-100,971
| -20% | -$40.6M | 0.32% | 55 |
|
|
2025
Q1 | $219M | Buy |
504,299
+12,989
| +3% | +$5.21M | 0.53% | 31 |
|
|
2024
Q4 | $181M | Sell |
491,310
-26,791
| -5% | -$11.2M | 0.47% | 34 |
|
|
2024
Q3 | $269M | Buy |
518,101
+7,146
| +1% | +$3.82M | 0.7% | 22 |
|
|
2024
Q2 | $277M | Buy |
510,955
+50,459
| +11% | +$26.7M | 0.77% | 19 |
|
|
2024
Q1 | $239M | Buy |
460,496
+21,006
| +5% | +$10.4M | 0.79% | 20 |
|
|
2023
Q4 | $207M | Buy |
439,490
+16,597
| +4% | +$7.67M | 0.74% | 20 |
|
|
2023
Q3 | $184M | Buy |
422,893
+51,227
| +14% | +$23.2M | 0.77% | 21 |
|
|
2023
Q2 | $165M | Buy |
371,666
+51,330
| +16% | +$23.7M | 0.67% | 27 |
|
|
2023
Q1 | $147M | Buy |
320,336
+30,000
| +10% | +$14.3M | 0.67% | 15 |
|
|
2022
Q4 | $149M | Buy |
290,336
+216,106
| +291% | +$110M | 0.73% | 13 |
|
|
2022
Q3 | $33.7M | Buy |
74,230
+813
| +1% | +$389K | 0.19% | 107 |
|
|
2022
Q2 | $35.4M | Buy |
73,417
+1,772
| +2% | +$877K | 0.19% | 105 |
|
|
2022
Q1 | $35.2M | Sell |
71,645
-5,066
| -7% | -$2.32M | 0.18% | 108 |
|
|
2021
Q4 | $35.6M | Sell |
76,711
-55
| -0.1% | -$23.1K | 0.15% | 145 |
|
|
2021
Q3 | $28.6M | Sell |
76,766
-5,181
| -6% | -$1.97M | 0.13% | 164 |
|
|
2021
Q2 | $31.3M | Sell |
81,947
-2,667
| -3% | -$1.02M | 0.14% | 154 |
|
|
2021
Q1 | $30.4M | Buy |
84,614
+78
| +0.1% | +$25.1K | 0.15% | 144 |
|
|
2020
Q4 | $27.1M | Buy |
84,536
+1,324
| +2% | +$406K | 0.14% | 145 |
|
|
2020
Q3 | $22.4M | Sell |
83,212
-2,598
| -3% | -$699K | 0.13% | 138 |
|
|
2020
Q2 | $22.6M | Buy |
85,810
+25,382
| +42% | +$6.77M | 0.14% | 127 |
|
|
2020
Q1 | $13.7M | Sell |
60,428
-2,216
| -4% | -$604K | 0.1% | 182 |
|
|
2019
Q4 | $18.9M | Sell |
62,644
-3,033
| -5% | -$835K | 0.11% | 161 |
|
|
2019
Q3 | $15.8M | Sell |
65,677
-31,415
| -32% | -$8.61M | 0.11% | 178 |
|
|
2019
Q2 | $27.4M | Sell |
97,092
-2,088
| -2% | -$570K | 0.19% | 112 |
|
|
2019
Q1 | $28.5M | Buy |
99,180
+852
| +0.9% | +$246K | 0.19% | 117 |
|
|
2018
Q4 | $25.8M | Sell |
98,328
-26,201
| -21% | -$7.2M | 0.19% | 117 |
|
|
2018
Q3 | $34.1M | Sell |
124,529
-4,578
| -4% | -$1.19M | 0.19% | 122 |
|
|
2018
Q2 | $30.7M | Sell |
129,107
-1,694
| -1% | -$392K | 0.18% | 125 |
|
|
2018
Q1 | $28.7M | Sell |
130,801
-12,329
| -9% | -$2.9M | 0.18% | 129 |
|
|
2017
Q4 | $32.2M | Sell |
143,130
-24,750
| -15% | -$5.27M | 0.18% | 134 |
|
|
2017
Q3 | $31.9M | Buy |
167,880
+2,070
| +1% | +$394K | 0.17% | 141 |
|
|
2017
Q2 | $31.2M | Buy |
165,810
+2,260
| +1% | +$406K | 0.17% | 136 |
|
|
2017
Q1 | $27.1M | Sell |
163,550
-9,432
| -5% | -$1.5M | 0.15% | 150 |
|
|
2016
Q4 | $24.9M | Buy |
172,982
+10,477
| +6% | +$1.4M | 0.15% | 152 |
|
|
2016
Q3 | $20.4M | Buy |
162,505
+3,863
| +2% | +$499K | 0.13% | 192 |
|
|
2016
Q2 | $20.8M | Buy |
158,642
+11,497
| +8% | +$1.57M | 0.14% | 165 |
|
|
2016
Q1 | $20.5M | Buy |
147,145
+2,217
| +2% | +$296K | 0.15% | 149 |
|
|
2015
Q4 | $20.2M | Sell |
144,928
-1,138
| -0.8% | -$157K | 0.15% | 151 |
|
|
2015
Q3 | $20.4M | Sell |
146,066
-11,374
| -7% | -$1.71M | 0.17% | 145 |
|
|
2015
Q2 | $25.8M | Buy |
157,440
+4,580
| +3% | +$732K | 0.18% | 130 |
|
|
2015
Q1 | $23.6M | Buy |
152,860
+26,034
| +21% | +$3.71M | 0.16% | 141 |
|
|
2014
Q4 | $15.9M | Buy |
126,826
+146
| +0.1% | +$18K | 0.12% | 190 |
|
|
2014
Q3 | $15.2M | Sell |
126,680
-3,824
| -3% | -$439K | 0.12% | 196 |
|
|
2014
Q2 | $14M | Sell |
130,504
-329
| -0.3% | -$33.9K | 0.11% | 221 |
|
|
2014
Q1 | $13M | Sell |
130,833
-5,730
| -4% | -$518K | 0.11% | 215 |
|
|
2013
Q4 | $12.6M | Buy |
136,563
+249
| +0.2% | +$22.1K | 0.11% | 219 |
|
|
2013
Q3 | $11.4M | Buy |
136,314
+17,728
| +15% | +$1.52M | 0.1% | 243 |
|
|
2013
Q2 | $9.71M | Buy |
+118,586
| New | +$8.87M | 0.1% | 235 |
|
Other funds holding ELV
Aviva's ELV Position: Q2 2026 in Review
Aviva increased its Elevance Health (ELV) stake by 0.87% in Q2 2026, buying an estimated $638K and bringing the position to 199,336 shares worth $77.1M. The position accounts for 0.11% of the portfolio, ranked #154.
Aviva first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $277M in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Aviva held 199,336 shares of Elevance Health worth $77.1M as of Q2 2026.
- Aviva bought 1,719 Elevance Health shares in Q2 2026, an estimated $638K.
- Elevance Health made up 0.11% of Aviva's portfolio in Q2 2026, its #154 holding.
- Aviva first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- Aviva's Elevance Health position peaked at $277M in Q2 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.